Cargando…
Effect of miR-183-5p on Cholestatic Liver Fibrosis by Regulating Fork Head Box Protein O1 Expression
Liver fibrosis is a common pathological feature of end-stage liver disease and has no effective treatment. MicroRNAs (miRNAs) have been found to modulate gene expression in liver disease. But the potential role of miRNA in hepatic fibrosis is still unclear. The objective of this research is to study...
Autores principales: | Wang, Yongxin, Chen, Bin, Xiao, Chengcheng, Yu, Jiang, Bu, Xiangyang, Jiang, Fengxing, Ding, Weijie, Ge, Zhong |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8639207/ https://www.ncbi.nlm.nih.gov/pubmed/34867446 http://dx.doi.org/10.3389/fphys.2021.737313 |
Ejemplares similares
-
Differential expression of microRNAs in bile duct obstruction-induced liver fibrosis and the identification of a novel liver fibrosis marker miR-1295b-3p
por: Bu, Xiangyang, et al.
Publicado: (2023) -
Cytochrome P450 Omega-Hydroxylase 4a14 Attenuates Cholestatic Liver Fibrosis
por: Li, Sha, et al.
Publicado: (2021) -
Expression of miR-127, miR-154, and miR-183 in Medullary Thyroid Carcinoma Tumors
por: RAHMANI SAMANI, Mahsa, et al.
Publicado: (2021) -
Plasma miR-19b and miR-183 as Potential Biomarkers of Lung Cancer
por: Zaporozhchenko, Ivan A., et al.
Publicado: (2016) -
miR-96 and miR-183 differentially regulate neonatal and adult postinfarct neovascularization
por: Castellan, Raphael F.P., et al.
Publicado: (2020)